Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$475,271
+$111,192 QoQ
Shares Held
136,181
+7.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. SANA ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $475,271 | 136,181 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $364,079 | 126,417 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $614,642 | 151,018 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $458,861 | 129,257 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $127,757 | 46,798 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $270,258 | 160,869 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $262,717 | 161,177 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $642,220 | 154,380 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $827,211 | 151,504 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,076,470 | 107,647 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $366,983 | 89,947 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $348,093 | 89,947 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $541,292 | 90,821 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $228,928 | 70,009 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $266,884 | 67,566 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $405,396 | 67,566 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $422,463 | 65,702 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $460,229 | 55,718 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $289,444 | 18,698 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $215,245 | 9,558 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $68,062 | 3,462 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $110,852 | 3,312 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||